chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills, followed by night sweats, slight fever. (99.8) Extremely uncomfortable (my body felt like I had ?lock jaw? all over it).  Extreme fatigue, head aches, and body aches. Ended at about 10pm on Tuesday 4/27.  Wednesday 4/28 at about 6 PM I noticed I had a huge lump under my left armpit  (same arm as injection) and it felt like it was growing, went away over a week.
Chest pains and shortness of breath within days of vaccination and sustained through December. Acute ST elevation myocardial Infarction STEMI on 12/10/21 at 8:50 PM.
This is a spontaneous report from a contactable pharmacist. An elderly patient of an unspecified gender who was over 65 years old, received PREVNAR 13 on an unspecified date at single dose for immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced swelling in the arm specifically on the injection site and it was warm to touch. The outcome of the events was unknown.
Hot flashes/About 30 minutes into after my vaccination, I started getting hot flashes.; Began to sweat; I apparently forgot that I had said some things.; The day ended with exhaustion; Flu or allergy-like symptoms; Stuffy yet also runny nose; Warm feverish face; Eyes that were watery; Eyes burning; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERS729) via an unspecified route of administration in the left arm on 11Apr2021 at 17:00(at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included obesity, blood pressure high, porphyria, anxiety, sulfonamide allergy and MRI Contrast Media dye allergy. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 17:30 about 30 minutes after vaccination, the patient started getting hot flashes. It was not hot in the room, but the patient began to sweat. Following that, the patient apparently forgot that he had said some things. The day ended with exhaustion and flu or allergy-like symptoms, stuffy yet also runny nose, warm feverish face, and eyes that were watery and burning. The clinical outcome of the events hot flashes, began to sweat, forgot had said something, exhaustion, flu or allergy-like symptoms, stuffy yet also runny nose, warm feverish face and eyes that were watery and burning was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Arm sore at the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm sore at the injection) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Glaucoma. Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse reaction.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm sore at the injection). At the time of the report, VACCINATION SITE PAIN (Arm sore at the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient was on eye drops for glaucoma as concomitant medication. No treatment medication information was given.   This case was linked to MOD-2021-367418, MOD-2021-367368 (Patient Link).
pt exp facial swelling & hives 1-2 hrs p/vax; treated w/EPI & DPH & Suspheride; later prescribed Pred;
Swollen left side lymph node at the base of the neck, with slight pain. Two weeks later right side lymph node at base of neck swells, but no pain. Also noticed under arm lymph nodes swollen two weeks after vaccination. No other symptoms.
Pt with c/o L shin, L thigh- front and back and L calf pain that started 15 mins post 1st Pfizer vaccine. Pt had been sitting in the monitoring area for 15 minutes and upon standing to walk out of the clinic, pt reported L shin, thigh and calf pain with walking or palpation by RN. He denied any chest pain, palpitations, SOB, dizziness, or headaches. ER MD notified and monitored. Pt VSS and he was released home with mom and advised to return to the ER should his symptoms not improve, changes, worsens or becomes life threatening.
Patient complained of not being able to move her arm and the pain was extreme. With a fever of 102 degrees. The next morning fever of 100 degrees F but still has problems with moving her arm and fingers. Pain is getting better but still has problems moving her arm.
26th I felt fatigue and I got a severe sore throat and headache all that week, I had congestion and fatigue. The cough developed badly for a week and now it gone away. It almost 3 weeks.
having hives; itching all over; voice changed; throat was feeling closed up / ER Visit Required; headache; fast heartbeat; This case was reported by a consumer via call center representative and described the occurrence of hives in a 81-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th May 2021, the patient received the 1st dose of Shingrix. On 13th May 2021, 7 days after receiving Shingrix, the patient experienced hives, generalized pruritus, voice alteration, throat constriction, headache and heartbeats increased. The patient was treated with benadryl (nos) (Benadryl) and triamcinolone. On an unknown date, the outcome of the hives and generalized pruritus were recovering/resolving and the outcome of the voice alteration, throat constriction, headache and heartbeats increased were not recovered/not resolved.   It was unknown if the reporter considered the hives, generalized pruritus, voice alteration, throat constriction, headache and heartbeats increased to be related to Shingrix.  Additional details were provided as follows: The patient received 1st dose of Shingrix and approximately 7 days later, the patient reported that his throat was feeling closed up and his voice changed and had itching all over and had hives. The patient also experienced headache and fast heartbeat. The patient went to the emergency room and was given Benedryl and an injection of triamcinolone. The patient noted some improvement in the itching and hives and all other events remain the same. The patient was not hospital overnight. No other contact information was available at time of report, but patient did give permission to contact their doctor. The reporter consented to follow up.
Soreness in injection site shoulder; slight body aches; headache; Felt like a cold coming on.; This is a spontaneous report from a contactable consumer (patient) via COVAES. A 65-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EP6955), via an unspecified route of administration on arm left on 27Mar2021 at 11:30 am as single dose for COVID-19 immunisation. Medical history included hypertension, depression and attention deficit hyperactivity disorder (ADD). Concomitant medications the patient received within 2 weeks of vaccination included venlafaxine; losartan; amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and hydrochlorothiazide. Previously, he had first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6202), via an unspecified route of administration, in arm left on 06Mar2021 at 02:00 pm as single dose for COVID-19 immunisation. On 27Mar2021, he received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at 11:30. The patient experienced soreness in injection site shoulder on, slight body aches, headache and felt like a cold coming on at 03:00 pm on 27Mar2021. No treatment was received for the reported events. Outcome of all events was recovered.  No follow-up attempts are needed. No further information is expected.
No additional AE's.; GARDASIL 9 that underwent a temperature excursion; Information has been received from a registered medical assistant reporting on a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication.  On 11-MAR-2021, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis, lot number 1687292 and expiration date 25-AUG-2022 (dose and route of administration were not reported). No adverse event.  On an unknown date, the vaccine underwent a temperature excursion between 36 and 46 Fahrenheit degree for 30 minutes; another temperature excursion between 36 and 46 Fahrenheit degree for 30 minutes was confirmed. No previous temperature excursions were reported. The call was placed because a digital data logger combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1687292; expirationdate: 25-AUG-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
For my first Pfizer shot I got fever of 102, chills, headache, muscle aches, malaise, weakness for 4 hours about 16 hours after shot. Following this, the headache and fatigue remained the rest of the day. Periodic headaches noted in the weeks following. After my second Pfizer Covid shot I experienced nausea, diarrhea, extreme fatigue and exhaustion, malaise 4 days are shot lasting about 24 hours in duration.
COVID; COVID; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old male patient received BNT162b2 (BNT162B2), on 13Nov2021 as dose 3 (booster), single (Lot number: FF2590) at the age of 32 years for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 25Jul2022 as dose 4 (booster), single (Lot number: 056A22A) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Multiple sclerosis" (unspecified if ongoing), notes: Immunosuppressant. The patient's concomitant medications were not reported.  The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 14Sep2022, outcome "unknown" and all described as "COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (14Sep2022) Positive, notes: Positive COVID antibody test. Therapeutic measures were taken as a result of covid-19, drug ineffective.  Clinical course: The patient had received anti viral therapy with product Paxlovid which was started on 01Sep2022 and stopped on 06Sep2022 for treatment of COVID-19.  No follow-up attempts are possible. No further information is expected.
Foot and mouth disease; This is a spontaneous report from contactable nurse (patient). A female patient of an unspecified age received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), intramuscular, administered in arm left on 06Jan2021 at 63-year-old (Lot Number: EL1283) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing, dermal filler injection from an unknown date and unknown if ongoing, herpes zoster from an unknown date and unknown if ongoing, guttate psoriasis from an unknown date and unknown if ongoing. Patient was not pregnant and was not pregnant at time of vaccination. Concomitant medications included vitamin d nos (VITAMIN D NOS) taken for an unspecified indication, start and stop date were not reported; acetylsalicylic acid (BABY ASPIRIN) taken for an unspecified indication, start and stop date were not reported; niacin (NIACIN) taken for an unspecified indication, start and stop date were not reported; atenolol (ATENOLOL) taken for an unspecified indication, start and stop date were not reported. The patient previously took the 1st dose of  bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech) on 16Dec2020 at 63-year-old (Batch/Lot# EJ1685) for COVID-19 immunisation, azithromycin (ZITHROMAX) and experienced drug hypersensitivity.  The patient was diagnosed with suspected foot and mouth disease (non-serious) in Apr2021 with outcome of unknown. No follow-up attempts are possible. No further information is expected. Sender's Comments: Linked Report(s) : PFIZER INC-202101529870 Same reporter/patient/drug, different dose/events.
Patient with Multiple Myeloma in Remission has a Autologous Stem Cell Transplant 4/7/2022, had stared revaccination series on 9/6/22 when she received her Pfizer Dose one, monovalent primary series vaccine #1.    Patient returned to clinic to receive her dose #2 monovalent primary series on 10/19/22 but was given the Pfizer bivalent booster vaccine instead.   The patient did not have an adverse reaction and tolerated the vaccine well.
Information has been received from a triage nurse concerning a female (age unknown) with no other pertinent medical history reported. On approximately 17 Oct 2006, the patient was vaccinated with a 0.5mL dose of Gardisal (yeast). There were no concomitant medications reported. On an unspecified date, the patient contacted the nurse complaining about pain and swelling of the lymph nodes, in the groin area on her right side. Unspecified medical attention was sought. At the time of this report, the outcome of the events were unknown. Additional information has been requested.
patient received the powder of Shingrix reconstituted with sterile water; patient received the powder of Shingrix reconstituted with sterile water; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: patient received the powder of Shingrix reconstituted with sterile water) and inappropriate dose of vaccine administered (Verbatim: patient received the powder of Shingrix reconstituted with sterile water). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt date: 02-AUG-2023 A pharmacist reported that a patient received the powder of Shingrix reconstituted with sterile water, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter consented to follow up.
This spontaneous report was received from Registered Nurse who reported that on unspecified dates a unknown number of patients (ages and gender not reported) were vaccinated with a dose of (Merck) PROQUAD which were improperly stored. No adverse effects were reported. This report is linked to MARRS 1410USA009955, 1410USA009956, 1410USA004588, 1410USA009958, 1410USA009959 and 1410USA009960. Additional information has been requested.
Pt developed blurry vision and burning to eyes  several minutes after vaccination. lasted for about 20 minutes. sx somewhat similar to hyperglycemia symptoms. Felt better after observation period as above. Well for dc home.
heightened reflux like symptoms; belching; spitting up; fussiness; fever as well around 100 degrees Fahrenheit; This spontaneous report was received from a physician and refers to a 2-month-old male patient.  The patient's concurrent conditions  included being fussy and colic like with belching and spitting up (all started since birth). The patient's mother had cut out dairy to help with these symptoms, and it was helping. His medical history was reported as none, concomitant medications were not reported.   On 09-APR-2021, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 2 milliliter, (lot # 1742457, expiration date reported as 16-JAN-2022, but upon internal validation established as 06-JAN-2022), administered orally for prevention of rotavirus. On the same day, he was vaccinated with  hib conj vaccine (tet toxoid), diphtheria toxoid, pertussis acellular 5-component vaccine, poliovirus vaccine inactivated (mrc-5), tetanus toxoid (PENTACEL) (strength, dose, route of administration, lot number, expiry date and indication were not reported) and with pneumococcal 13v conj vaccine (crm197) (PREVNAR 13) (strength, dose, route of administration, lot number, expiry date and indication were not reported).  On the same day, the patient experienced heightened reflux like symptoms, he was worse again with fussiness (severe), belching and spitting up. He had a fever as well around 100 degrees Fahrenheit for one day after the vaccine. The mother was feeling like he was back to or worse than before he had the vaccine. The patient sought medical attention. No treatment was administered due to the events and no laboratory diagnostics was performed. The outcome of the events was not reported.  The causal relationship between the events and the suspect vaccines was unknown. Since the patient received all suspect vaccines on the same day, the physician was not sure which vaccine or vaccines caused side effects.
No problem with actual injection but next few days arm became more sore than usual after receiving injection.  Had aching and pain from  left back of neck to injection site with some swelling at back of neck and shoulder.  Also had discomfort with movement of left arm such as when putting on jacket. Person took ibuprofen.  Symptoms are gradually decreasing.
On 2/14/00, he developed some lethargy and a morbilliform rash over most of his body and some pruritus. He also, has slight rhinitis. Dx: probable reaction to MMR #1, discussed with mother and warned about distress. May use Benadryl for itching. Follow-up as needed. Mother to have Pediatric consultation prior to continuing immunizations.
Pt came into pharmacy on 3-18-14 to report that 3 days after receiving ZOSTAVAX vaccine she was so sick she couldn't get out of bed. Later she had a cough for which she bought OTC med. On 3-16-14 she developed a rash on face.
Patient stating after vaccine he experienced inability to walk that lasted a day, shortness of breath, chills, achiness, muscle pains, fever and typical flu like symptoms. He stated he took Tylenol # 3 to help with the all the symptoms he was experiencing.
Infant received adult dose; Infant received adult dose; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 9-week-old female patient who received HBV (Engerix B adult) (batch number 39TZ2, expiry date 7th September 2023) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 15th February 2022, the patient received Engerix B adult and Engerix B Pre-Filled Syringe Device. On 15th February 2022, unknown after receiving Engerix B adult and Engerix B Pre-Filled Syringe Device, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.   This report is made by without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter stated that, the patient received an adult dose of the Engerix-b, which led to overdose and adult product administered to child. No reactions were reported.  The Vaccine administration facility was the same as Primary reporter. The reporter consented to follow up via email.
On 10/27/01, pt had itching on anterior left forearm and scratched. It was followed by "small, red bumps". Then the left arm and hand curled upward, elbow flexed for 1 second every second. While arm is having trouble, left leg goes numb while walking. She states she only stops when this happens and has never fallen due to this condition. The pt states she has periodic burning and that the rash only lasted 15 minutes. She states that the paralytic condition has happened 4 times in the last 15 minutes. She cannot be specific with time frames or period of times in which this condition lasts or intervals of occurrence. She has not been to see a PCP but has been strongly encouraged to do so.
Redness with heat at injection site. Along with rash, chills and muscle pain starting at injection site radiating to left side of neck.  Employee took Tylenol for pain with only 2 hours of relief from pain.
No additional AE's and no PQC's were reported.; An improperly stored dose of VARIVAX was administered to a patient.; This spontaneous report was received from a medical assistant  and refers to a patient of unknown age and gender  The patient's medical history, concurrent conditions, concomitant therapies and drug reactions or allergies were not reported.  On 09-APR-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, used as directed to prevent varicella infection, lot #T017685, which was confirmed to be a valid number, and expiration date: 21-MAY-2022, administered for prophylaxis (dose, vaccination scheme frequency, route of administration, and anatomical location were not provided). It was reported that the patient did not experienced any adverse event.
Patient completed both vaccines in series, first dose on 12/31/20 and the second dose on 1/22/21. He then began developing symptoms on 4/17/21 and tested positive 4/20/21.
February 1999 began limping. Blood test for Lyme and Leukemia at hospital (3/10/99). Tests were negative. Generally has joint pain; at times severe.
pt recvd vax c/o feet itching when mom was running errands p/leaving the church; mom states took shoes off & then told mom felt sick; vomited in car & then again @ home; skin reddened splotchy; bumpy, pt uncomfortalbe; flush
soreness at injection site; This is a spontaneous report from a non-contactable consumer.   A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in arm left on 12Feb2021 (Lot Number: EL3247) as single dose for covid-19 immunization.  Medical history included high blood pressure from an unknown date. No known allergies were noted. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) taken for an unspecified indication, start and stop date were not reported; loratadine (MANUFACTURER UNKNOWN) taken for an unspecified indication, start and stop date were not reported.  The patient experienced soreness at injection site on 12Feb2021, at 18:00 with outcome of recovering.    No follow-up attempts are possible. No further information is expected.
8-16-13 Received vaccine. 8-19-13 started running low grade fever (101 degrees) 8-26-13 rash on face, neck, chest, and back and continue low grade fever. 8/30/13 rash "pretty much gone."